IP Verse

Medical Injection Device Packaging

PatentPatent Analysis

EP3554581

TEVA PHARMACEUTICALS
Application Number
EP17816751A
Filing Date
Dec 13, 2017
Status
Granted And Under Opposition
Feb 9, 2024
Grant Date
Mar 13, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4097091B1
EP3497104B1
EP3344607B1

Bibliography

The patent EP3554581B1 was granted to Teva Pharmaceuticals on Mar 13, 2024 following the initial filing on Dec 13, 2017 under the application number EP17816751A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HOFFMANN EITLEDec 13, 2024ADMISSIBLE
YPSOMEDDec 13, 2024ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents